Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PlasmACT

Financiado

Plasma Medicine against Actinic Keratosis

The quality of human (and veterinary) health care systems substantially depends on key innovations. Often, these were driven by the field of physics, followed by interdisciplinary and inter-sectorial actions in engineering, chemis... ver más

31/12/2027

INP GREIFSWALD

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

LEIBNIZINSTITUT FUR PLASMAFORSCHUNG UND TECHN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 16 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-05-11

HORIZON-MSCA-2022-DN-01-01: MSCA Doctoral Networks 2022 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

16 Participantes

INP GREIFSWALD

521.08K€ | Lider

MOLECULAR PLASMA GROUP SA

N.D. | Participante

UANTWERPEN

525.24K€ | Participante

INSTITUT FUR IMPLANTATTECHNO...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

XMED Medical Phase Contrast X ray Imaging with Laser Plasma Accel... 150K€ Cerrado

MICROSCOPIO FOTOACÚSTICO CON CAPACIDAD DE IMA... MICROSCOPIO FOTOACÚSTICO CON CAPACIDAD DE IMAGEN SUBCUTÁNEA... 328K€ Cerrado

PLEC2022-009277 Plasma frío a presión atmosférica: una terapia física para l... 249K€ Cerrado

IgnitePLASMA A minimally Invasive surgical platform aGainst paNcreatIc an... 3M€ Cerrado

PID2021-125096NB-I00 INNOVACION, DESARROLLO Y MEJORA DE LOS TRATAMIENTOS PERSONAL... 48K€ Cerrado

UFRISED Ultra-sensitive Field-resolved Infrared Spectroscopy for Ear... 190K€ Cerrado

Duración del proyecto: 55 meses Fecha Inicio: 2023-05-11
Fecha Fin: 2027-12-31

Líder del proyecto

LEIBNIZINSTITUT FUR PLASMAFORSCHUNG UND TECHN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The quality of human (and veterinary) health care systems substantially depends on key innovations. Often, these were driven by the field of physics, followed by interdisciplinary and inter-sectorial actions in engineering, chemistry, biology, and medicine, such as X-rays in medical diagnostics, ionizing radiation in cancer treatment, and femtosecond lasers for precision surgery. Medical gas plasma technology was introduced to human health care a decade ago. Today, accredited medical plasma devices are in daily operation in dozen dermatology centers in middle Europe to improve wound healing. In addition, physical plasmas were shown to inactivate cancerous cells. Actinic Keratosis is a skin disease affecting millions of Europeans and making them prone to invasive and deadly skin cancer. Many of the available treatment options are associated with low efficacy, pain, risks, and/or high costs. Medical gas plasma technology is operated at body temperature and applied painlessly, cost-effectively, and without notable side effects. Gas plasma has been suggested to be active on high-grade cancer cells, but its activity against premalignant cells, as in Actinic Keratosis, is unknown. By using beyond state-of-the-art plasma multijet technology, the primary technical objective of PlasmACT – Plasma against Actinic Keratosis – is to support skin cancer prevention by medical gas plasma therapy of Actinic Keratosis. PlasmACT does so by educating a new generation of application-oriented scientists that are exposed to questions and findings from different scientific fields (interdisciplinary from physics over chemistry and biology to medicine) and capable of addressing questions in view of both academic as well as business needs (inter-sectoral) while incorporated in a vivid and productive environment across borders and cultures (international).

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores